Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Finasteride improves hair loss in women with hyperandrogenism.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Diane 35 plus finasteride is more effective for treating hirsutism.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

All three treatments reduce hirsutism, but spironolactone works best long-term.